Cleared Traditional

K863053 - ALT S.C.E. (GPT)

K863053 is an FDA 510(k) clearance for ALT S.C.E. (GPT), manufactured by J. D. Assoc.. The device is a Class 1 Chemistry device with product code CKA cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K863053 · J. D. Assoc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1986
Decision
120d
Days
Class 1
Risk

K863053 is an FDA 510(k) clearance for the ALT S.C.E. (GPT). Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by J. D. Assoc. (Montclair, US). The FDA issued a Cleared decision on December 10, 1986 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all J. D. Assoc. devices

FDA 510(k) Submission Details - K863053

510(k) Number K863053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1986
Decision Date December 10, 1986
Days to Decision 120 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 88d · This submission: 120d
Pathway characteristics
Predicate-based equivalence.

CKA Device Classification - Class 1, General Controls

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 117
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K863053.
WAKO(TM) AUTOKIT GPT
K864850 · Wako Chemicals USA, Inc. · Jan 1987
ALANINE AMINO TRANSFERASE ALT/SGPT
K864906 · Tech-Co, Inc. · Dec 1986
WAKO GPT II - HA
K864335 · Wako Chemicals USA, Inc. · Dec 1986
EMDS(TM) ALANINE AMINOTRANSFERASE (ALT) #67658/95
K863962 · Em Diagnostic Systems, Inc. · Nov 1986
ALT/GPT PROCEDURE
K863253 · Data Medical Associates, Inc. · Sep 1986
MODEL 303-47/303-48 ALANINE AMINOTRANSFERASE KIT
K862833 · Diagnostic Chemicals, Ltd. (Usa) · Aug 1986